SBIR/STTR Research Award
SBIR TOPIC 97 - PHASE II - MINIMALLY INVASIVE TEST FOR CHEMOTHERAPY-INDUCED CARDIOTOXICITY
Award amount
$727,427Program and phase
SBIR · Phase IIAward year
2019Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ACCEL DIAGNOSTICS, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- QUJ4EFCK59N4
- Solicitation number
- Not reported
- Topic code
- NHLBI
Research abstract
Cardiovascular toxicityCVTxis a serious short and long term complication of many anti cancer chemotherapeutic regimensZamoranoLancellotti et alIn this PhaseSBIR submission to continue the development and validation of Accel Diagnosticsminimally invasiverapidcost effective and connected blood testthe pScreen CVTx TMfor the early detection and continuous of chemotheropy induced CVTx
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- A COVID-19 Point of Care Serological Assay for Rapid Quantification of Antibody Titer.
- A COVID-19 Point of Care Serological Assay for Rapid Quantification of Antibody Titer.
- A rapid blood test to aid the triage of patients affected by head injuries.
- A Rapid Non-Invasive Device for Monitoring Preeclampsia inHigh Risk Pregnancy
- A disposable assay for the monitoring of heart failure in the home setting.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY
- Head Up CPR and Aortic Occlusion to Improve Survival after Refractory Cardiac Arrest
- Free-Breathing Dynamic Cardiopulmonary Function Imaging System to use with Xenon MRI
- The Next Wave of Asthma Therapeutics
- Bearingless flux reversal motor for neonatal and pediatric extracorporeal life support applications
Research funding history
9 SBIR/STTR records share this UEI (2012–2022). Reported award amounts total $4,754,609. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services